Editas Medicine, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

EDIT

organization

SIC: 2836

Also known as: EDITAS MEDICINE, INC.

SEC Insider

$75.3M

594 transactions

Summary

Editas Medicine, Inc. (EDIT) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $4.7MSales: $67.3M65 insiders

Date	Insider	Type	Value
2026-06-03	O'Neill Gilmore Neil(CEO)	Sell	$42K
2025-09-03	O'Neill Gilmore Neil(CEO)	Sell	$15K
2025-12-03	O'Neill Gilmore Neil(CEO)	Sell	$12K
2026-03-03	O'Neill Gilmore Neil(CEO)	Sell	$11K
2026-06-03	Burkly Linda(EVP, CHIEF SCIENTIFIC OFFICER)	Sell	$2K
2025-09-03	Burkly Linda(EVP, CHIEF SCIENTIFIC OFFICER)	Sell	$2K
2025-12-03	Burkly Linda(EVP, CHIEF SCIENTIFIC OFFICER)	Sell	$2K
2026-03-03	Burkly Linda(EVP, CHIEF SCIENTIFIC OFFICER)	Sell	$2K
2026-06-03	Parison Amy(SVP, Chief Financial Officer)	Sell	$1K
2025-09-03	Parison Amy(SVP, Chief Financial Officer)	Sell	$1K
2025-12-03	Parison Amy(SVP, Chief Financial Officer)	Sell	$991.15
2026-03-03	Parison Amy(SVP, Chief Financial Officer)	Sell	$957.48
2026-06-17	Levy Elliott M.	A	$0
2026-06-17	Scadden David	A	$0
2026-06-17	Hirsch Andrew	A	$0
2026-06-17	Hopfield Jessica	A	$0
2026-06-17	Connaughton Bernadette	A	$0
2026-03-12	Burkly Linda(EVP, CHIEF SCIENTIFIC OFFICER)	A	$0
2026-03-12	Parison Amy(SVP, Chief Financial Officer)	A	$0
2026-03-12	O'Neill Gilmore Neil(CEO)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Editas Medicine, Inc. — Contributions, Lobbying & Contracts | Poliscope